✦ LIBER ✦

P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study

✍ Scribed by D. Michelson; L.A. Adler; J.D. Amsterdam; D.L. Dunner; A.A. Nierenberg; F.W. Reimherr; A.F. Schatzberg; D.K. Kelsey; P.D. Feldman; L.R. Levine; D.W. Williams

Book ID: 118592717
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 77 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70295-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.a.010 Treatment of postpartum depres

P.2.a.010 Treatment of postpartum depression with psychotherapy and add-on sertraline: a double-blind, randomised, placebo-controlled study

✍ M. Bloch; H. Meiboom; M. Lorberblat; I. Aharonov; I. Bluvshtein; S. Ben-Itzhak; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 75 KB

P.2.h.001 A double-blind, randomized, pl

P.2.h.001 A double-blind, randomized, placebo-controlled study of quetiapine XR for the treatment of major depression and fibromyalgia

✍ McIntyre, A.; Paisley, D.; Kuoassi, E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

P.2.c.015 A randomised, double-blind, pl

P.2.c.015 A randomised, double-blind, placebo-controlled, active-referenced study of the multimodal antidepressant Lu AA21004 in the treatment of elderly depressed patients

✍ C. Katona; T. Hansen; C.K. Olsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Efficacy and safety of olanzapine for tr

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study

✍ Hideaki Katagiri, Mauricio Tohen, David P McDonnell, Shinji Fujikoshi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 226 KB

The cyclooxygenase-2 inhibitor celecoxib

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

✍ Müller, N; Schwarz, M J; Dehning, S; Douhe, A; Cerovecki, A; Goldstein-Müller, B 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB